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Endometrial Stromal Sarcomas are rare malignant tumours of the uterus. We report the case of incidental
ﬁnding of Low-Grade Endometrial Stromal Sarcoma (LGESS) that metastasized to the retroperitoneum 14
years after the original surgery in a 72-year-old woman. The patient underwent a laparotomy and
excision of all tumour nodules. Considering the common recurrence of and slow growing nature of
LGESS, appropriate treatment options like surgical excision and life-long follow up should be considered.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Malignancy of the uterine corpus is the fourth most common
cancer in women living in developed countries worldwide. Endo-
metrial Stromal Sarcoma (ESS) is a rare neoplasm comprising only
0.2% of all uterine malignancies and 15e26% of primary uterine
sarcomas with less than 700 cases diagnosed annually.1 ESS was
formerly classiﬁed into two distinct subtypes, low-grade and high-
grade, based on differences in morphological atypia and prolifera-
tive activity. The World Health Organization (WHO) re-classiﬁed
these entities into three groups: benign endometrial stromal
nodule (ESN), low-grade endometrial stromal sarcoma (LGESS), and
undifferentiated endometrial sarcoma (UES).2 LGESS is a slow
growing tumorwith good prognosis and a 50% recurrence following
treatment. Common metastatic sites for LGESS are the vagina,
pelvis, and peritoneal cavity although distant metastasis to sigmoid
colon, lung, liver, brain, has also been reported.3 We present a case
of low-grade ESS that recurred 14 years following the original
surgery with metastasis in the retroperitoneal.Case presentations
A 72-year-old woman presented with dyspnea and bilateral pe-
ripheral edema. She had undergone total hysterectomy for low-gradeacquarie University Hospital,
tmail.com (C. Varol).
Inc. This is an open access article uendometrial stromal sarcoma (LGESS) tumor fourteen years prior,
which was conﬁrmed histologically to be LGESS. There were no
signiﬁcant pastmedical history or history of familial disease. Physical
examination showed palpable abdominal mass at the Right Lower
Quadrant and Left Lower Quadrant. The following tumor markers
(AFP, CEA, Cancer Antigen 125, and BhCG) arewithin reference limits.
Yet, normal results do not exclude neoplasia. CT scan of the abdomen
and pelvis revealed presence of several retroperitoneal masses sur-
rounding the abdominal aorta and vena cava (Fig. 1). Percutaneous
biopsy of the lesion showed diffuse proliferation of spindle-shaped
cells with little nuclear atypia. Morphologically, the tumor re-
sembles the tumor from the 1993 histopathology specimen.
The patient underwent a laparotomy and excision of all tu-
mor nodules. Seven nodular masses were excised weighing
altogether 1042 g (Fig. 2). The largest nodule measured
160  100  80 mm in dimension (Fig. 3) and the smallest was
20 x 20  12 mm. The largest nodule impinges upon the right
ureter, right kidney and iliac vessels. The external surfaces of all
these nodules appear lobulated, multinodular, and covered by a
serosal surface that formed a capsule. This enabled easy excision
during surgery.
The patient’s postoperative course was uneventful. She was free
of symptoms 2 weeks following abdominal surgery.
Discussion
Clinical characteristics of low-grade ESS (LGESS) include a
slow growth and indolent disease course with a tendency fornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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before recurrence varied from 3 months to 23 years, with a
median interval of 3 years. 50% of patients with low-grade
ESS develop recurrences or metastases in the vagina, pelvis,
and peritoneal cavity although distant metastasis has been
reported.4
Although outdated, ESS was formerly classiﬁed into low-grade
ESS and high-grade ESS based on differences in the cell’s mitotic
activity. More than 10 mitotic ﬁgures for high-grade ESS and less
than 10 mitotic ﬁgures per 10 HPF for low-grade ESS. Microscopic
examination of the tumor showed that it hasmitotic count less thanFigure 1. Abdominal & pelvic CT scans which revealed presence of several retro10 in mitosis per high power ﬁelds (HPF) e thus classifying the
tumor as low-grade ESS rather than high-grade ESS.
Surgical excision is currently the only therapeutic procedure
for LGESS. Standard treatment for its recurrent disease such
as radiotherapy and chemotherapy has not been established
to be effective. Immunoreactivity for estrogen receptor and
progesterone receptor is not regularly assessed in LGESS. Based
on several clinical studies, Mansi et al recommended that
progesterone therapy should be the treatment of ﬁrst choice
for relapsed LGESS because there was resolution or stabilization
of recurrent or metastatic disease in more than 50% of patientsperitoneal masses surrounding the abdominal aorta and inferior vena cava.
Figure 2. Seven nodularmasses that were excised. They weighed 1042 g with the largest
measuring 160  100  80 mm and the smallest measuring 20  20  12 mm.
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worthy since our tumor sample showed strong and diffuse
staining against anti-estrogen and progesterone receptor
antibodies.Figure 3. The largest nodule excised. It impinges upon the right ureter, right kidney,
and iliac vessels. Causing lower extremity edema.Conclusion
Considering the slowgrowing nature and common recurrence of
LGESS, 14 years’ recurrences in this case, a life-long follow up and
routine assessment for anti-estrogen and anti-progesterone should
be integrated into clinical practice in LGESS management. Any sign
of recurrence should be managed with surgical excision.Ethical approval
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